Block 1 — Bile Physiology & Enterohepatic Circulation
5 questions · LOs 1, 2
⏱
07:30
Block Timer
Instructions: Select the single best answer for each question. Your answer locks in when you click; the explanation will appear. Manage your time to complete 5 questions in 7.5 minutes.
Question 1 of 5 — LO 1 · Unstirred Water Layer
A 62-year-old man with a lifelong high-cholesterol diet and sedentary lifestyle is evaluated for recurrent episodes of abdominal discomfort. His son asks why dietary lipids need special processing before the body can absorb them. The gastroenterologist explains that lipid molecules are too large and hydrophobic to cross the epithelial barrier directly. Which anatomical barrier prevents lipid diffusion, and how is it overcome in healthy fat absorption?
AThe gastric mucosa; lipids are emulsified by acid pepsin
BThe unstirred water layer coating the brush border; bile salts form micelles to solubilize lipids
CThe tight junctions between enterocytes; chylomicrons bypass the junction
DThe lamina propria; albumin transports lipids through the bloodstream
EThe brush border; pancreatic amylase breaks down lipid polymers
B — The unstirred water layer; bile salts form micelles. The unstirred water layer (UWL) is a thin, non-turbulent layer of fluid clinging to the brush border epithelium. Lipids are amphipathic molecules and cannot cross this hydrophilic barrier on their own. Bile salts, which are amphipathic, surround hydrophobic fats to form micelles — allowing lipids to pass through the UWL and reach the enterocyte surface. Without adequate bile, lipid absorption fails (steatorrhea). Pancreatic lipase and colipase work upstream, fragmenting triglycerides into 2-monoglycerides and fatty acids that must then be solubilized.
Question 2 of 5 — LO 2 · Bile Synthesis & CCK
A 45-year-old woman with early primary biliary cholangitis presents with pruritis and elevated alkaline phosphatase. Her daughter, a medical student, asks why postprandial (after eating) pruritis is worse. The physician explains that the normal meal trigger initiates a hormonal cascade. Which hormone released in response to dietary fat and protein directly causes gallbladder contraction, and from which cell type is it released?
ASecretin from S-cells; it stimulates pancreatic bicarbonate secretion only
BCholecystokinin (CCK) from I-cells of the duodenum; it triggers both gallbladder contraction and pancreatic enzyme secretion
CGastrin from G-cells; it increases intragastric pressure to expel bile mechanically
DMotilin from M-cells; it promotes antral grinding for bile emulsification
EVIP from vagal nerve terminals; it relaxes the pylorus to allow bile entry into the duodenum
B — CCK from I-cells; gallbladder contraction + pancreatic enzyme secretion.Cholecystokinin (CCK) is released by I-cells of the duodenum and jejunum in response to fat and protein. CCK has two major effects: (1) gallbladder contraction + relaxation of the sphincter of Oddi → bile flows into the duodenum, and (2) stimulation of pancreatic enzyme secretion (lipase, proteases, amylase). In this patient with bile duct inflammation, increased bile delivery triggers postprandial symptoms.
Question 3 of 5 — LO 1 · Micelle Formation
A 34-year-old man with Crohn's disease involving the terminal ileum is counseled about his expected postoperative status. His gastroenterologist mentions that bile acid recirculation plays a critical role in lipid absorption. Which liver enzyme catalyzes the rate-limiting step of bile acid synthesis FROM cholesterol, and where are the majority of bile acids reabsorbed?
AHMG-CoA reductase; in the proximal jejunum via passive diffusion
BCholesterol 7α-hydroxylase; in the stomach via proton-dependent cotransport
CCholesterol 7α-hydroxylase; in the terminal ileum via active transport (ASBT)
DAcetyl-CoA carboxylase; in the distal colon via bacterial conjugation
EPhospholipid transferase; in the duodenum via receptor-mediated endocytosis
C — Cholesterol 7α-hydroxylase; terminal ileum via ASBT.Cholesterol 7α-hydroxylase (CYP7A1) catalyzes the first committed step of bile acid synthesis from cholesterol (rate-limiting step). The majority (95%) of bile acids are recirculated via enterohepatic circulation: reabsorbed in the terminal ileum by the apical sodium-dependent bile acid transporter (ASBT), and returned to the liver via the portal vein. After resection of the terminal ileum, this recirculation is lost → bile acid pool depletion → steatorrhea + bile acid diarrhea.
Question 4 of 5 — LO 2 · Colipase Function
A 7-year-old boy with cystic fibrosis is prescribed pancreatic enzyme replacement therapy. His parents ask why the enzymes must include a component called "colipase" in addition to lipase alone. Which statement best explains colipase's critical role in lipid digestion?
AColipase synthesizes new bile acids to replace those lost in diarrhea
BColipase forms micelles with fatty acids to enhance solubility
CColipase prevents bile salts from inhibiting pancreatic lipase, allowing enzyme-substrate contact
DColipase activates enterocyte brush border lipases for secondary fat digestion
EColipase catalyzes the glycosidic bonds in carbohydrate-bound triglycerides
C — Colipase prevents bile salt inhibition of pancreatic lipase.Pancreatic lipase fragments triglycerides into 2-monoglycerides and fatty acids in the lipid-water interface of the duodenal lumen. However, bile salts inhibit lipase when present at high concentrations (paradoxical inhibition). Colipase, a pancreatic cofactor, binds lipase and helps it resist bile salt inhibition, maintaining enzyme activity at the oil-water interface. In CF, exocrine pancreatic insufficiency eliminates both lipase AND colipase → severe fat malabsorption without bile involvement.
Question 5 of 5 — LO 1 · Cholesterol Homeostasis
A 58-year-old man with elevated LDL cholesterol is started on atorvastatin. His pharmacologist explains that the drug blocks the rate-limiting enzyme of cholesterol synthesis. Which enzyme is inhibited by statins, and by what mechanism does this reduce bile acid production?
AAcetyl-CoA carboxylase; bile acids are not cholesterol-derived
BHMG-CoA reductase; statin blocks cholesterol synthesis → less substrate for 7α-hydroxylase → reduced bile acid synthesis
CCholesterol 7α-hydroxylase; directly inhibiting the bile acid pathway
DFatty acid synthase; bile acids are synthesized from acetyl-CoA
ELCAT; bile acids require lecithin-cholesterol acyltransferase maturation
B — HMG-CoA reductase inhibition reduces cholesterol substrate for 7α-hydroxylase.HMG-CoA reductase is the rate-limiting enzyme of cholesterol synthesis. Statins competitively inhibit HMG-CoA reductase → decreased hepatic cholesterol → decreased substrate availability for cholesterol 7α-hydroxylase (the committed step of bile acid synthesis). This two-step mechanism (↓ cholesterol → ↓ primary bile acid synthesis) is indirect but effective. LDL receptors are also upregulated, further lowering serum cholesterol.
Instructions: Select the single best answer for each question. Focus on recognizing disease patterns and their hepatobiliary consequences.
Question 6 of 5 — LO 3 · Biliary Colic & Gallstones
A 48-year-old woman with a BMI of 32 presents to the ED with sudden-onset right upper quadrant pain radiating to the right shoulder that began 30 minutes after a fatty dinner. She is afebrile and non-icteric. Abdominal ultrasound shows a gallbladder containing two 8-mm echogenic foci with posterior acoustic shadowing, a normal common bile duct (3 mm), and normal liver echotexture. What is her diagnosis, and which hormone directly caused her symptoms tonight?
EPeptic ulcer disease; increased splanchnic blood flow from dietary fat
B — Biliary colic from cholelithiasis; CCK-triggered contraction against stones. This is the classic presentation of biliary colic: acute RUQ pain after a fatty meal, relieved within 30 min to several hours. Ultrasound confirms cholelithiasis (gallstones) with posterior acoustic shadowing. Pathophysiology: dietary fat triggers CCK release from I-cells → gallbladder contraction → stone lodges in the cystic duct → pain. No fever, no elevated WBC, normal CBD, normal parenchyma = not cholecystitis or cholangitis. Management: supportive care, then elective cholecystectomy.
Question 7 of 5 — LO 2 · Obstructive Jaundice Pattern
A 62-year-old man with a history of biliary colic presents with new-onset yellowing of the skin and sclera over the past 3 days, dark urine, and pale ("clay-colored") stools. He denies fever. LFTs show: total bilirubin 8.2 mg/dL (conjugated 7.1), ALP 320 U/L, AST/ALT normal, albumin normal. Ultrasound reveals a 5-mm stone in the distal common bile duct and gallbladder stones. Explain the relationship between the bile duct obstruction and his clinical presentation.
AStone-induced hepatocyte necrosis releases AST/ALT; hyperbilirubinemia is unconjugated
BCBD obstruction prevents bile excretion → conjugated bilirubin backs up into blood → filtered by kidneys (dark urine); no stercobilin formed (pale stools)
DObstruction causes pancreatic exocrine insufficiency → steatorrhea and fat-soluble vitamin malabsorption only
ECystic duct blockade prevents stored bile release; hepatic bile synthesis is reduced
B — Conjugated bilirubin backup → dark urine; absent stercobilin → pale stools. This is the classic obstructive jaundice pattern. Mechanism: CBD stone completely blocks bile flow → bile cannot reach the intestine → no stercobilin production (which gives stool brown color) → pale stools. Meanwhile, conjugated (direct) bilirubin accumulates in hepatocytes, backs up into the bloodstream, and is filtered by glomeruli → bilirubinuria (dark urine). The jaundice here is conjugated (indirect bilirubin = 0), and transaminases are normal (no hepatocyte injury). AST/ALT would be elevated in acute cholangitis with infection.
Question 8 of 5 — LO 2 · PBC vs PSC
A 42-year-old woman with a 6-year history of Crohn's disease is found to have elevated alkaline phosphatase (ALP 280) and anti-mitochondrial antibodies (AMA) on routine labs. She reports 3 months of progressive pruritis and mild jaundice. Liver biopsy shows granulomatous inflammation destroying intrahepatic bile ducts. What is her diagnosis, and which is the standard first-line pharmacologic treatment?
B — Primary biliary cholangitis; AMA positive; first-line treatment = UDCA.Primary biliary cholangitis (PBC) is an autoimmune cholestasis targeting intrahepatic bile ducts. Key diagnostic features: predominantly middle-aged women, anti-mitochondrial antibodies (AMA) highly specific, granulomatous destruction on biopsy, and cholestatic LFTs (↑ ALP, ↑ bilirubin, normal/mildly elevated transaminases). Pruritis is hallmark. Ursodeoxycholic acid (UDCA) is the standard first-line therapy — it slows disease progression and improves survival. PSC (which can occur in Crohn's) targets intra- AND extrahepatic ducts, shows p-ANCA, and has a worse prognosis.
Question 9 of 5 — LO 3 · Ampulla of Vater & Pancreatobiliary Junction
A 55-year-old woman with a history of biliary colic passes a gallstone into the duodenum 2 days ago (confirmed on imaging). She now presents with acute severe epigastric pain, elevated serum lipase (680 U/L), and elevated amylase. Imaging shows a stone impacted at the ampulla of Vater. Why does an ampulla of Vater stone cause BOTH obstructive jaundice AND acute pancreatitis?
AThe ampulla controls both hepatic and pancreatic venous outflow; obstruction increases organ pressure equally
BThe ampulla is where CBD and pancreatic duct merge; a stone blocks both ducts simultaneously
CPancreatic inflammation causes secondary bile reflux into the hepatic parenchyma
DThe sphincter of Oddi coordinates both pathways; stone-induced inflammation increases intrabiliary pressure only
B — Ampulla is the junction of CBD and pancreatic duct; stone blocks both simultaneously. The ampulla of Vater is the anatomical point where the common bile duct (CBD) and pancreatic duct converge before entering the duodenum. A stone impacted here blocks both passages: (1) bile backflow → obstructive jaundice (conjugated hyperbilirubinemia, dark urine, pale stools), and (2) pancreatic duct obstruction → increased intrinsic pancreatic pressure → pancreatic enzyme leakage into parenchyma → acute pancreatitis. This is a classic "two-for-one" complication and a surgical emergency.
Question 10 of 5 — LO 3 · Ascending Cholangitis
A 67-year-old man with choledocholithiasis (CBD stone) is admitted with fever (39.2°C), right upper quadrant pain, and jaundice (bilirubin 5.8 mg/dL). Blood cultures are pending. He appears toxic and septic. Which classic triad best describes his condition, and why is this a medical emergency requiring immediate biliary decompression?
AMurphy's sign, sonographic "double-halo" sign, elevated GGT; condition is cholecystitis
BCharcot's Triad: Fever + Jaundice + RUQ Pain = ascending cholangitis (infected bile behind obstruction); risk of sepsis/shock
CCourvoisier's sign (palpable GB), elevated ALP alone, pale stools; condition is obstructive jaundice
DCullen's sign, Turner's sign, elevated lipase; condition is acute pancreatitis from a stone
ERovsing's sign, rebound tenderness, leukocytosis; condition is acute appendicitis with referred pain
B — Charcot's Triad: Fever + Jaundice + RUQ Pain = ascending cholangitis.Ascending cholangitis is infection of the bile ducts, typically caused by bacteria ascending past an obstruction (stone, stricture, or malignancy). The classic Charcot's Triad (fever, jaundice, RUQ pain) is diagnostic. This is a MEDICAL EMERGENCY because the infected, obstructed biliary system can rapidly progress to sepsis and septic shock (mortality ~15% with treatment, ~100% untreated). Management: IV antibiotics IMMEDIATELY + urgent biliary decompression (ERCP with sphincterotomy and stone removal, or percutaneous transhepatic cholangiography if ERCP fails).
Instructions: Select the single best answer for each question. These questions integrate multiple LOs and require differential diagnosis of steatorrhea causes.
Question 11 of 5 — LO 4 · ZES & Steatorrhea
A 48-year-old man with a history of refractory peptic ulcer disease and chronic diarrhea is found to have a serum gastrin level of 1,800 pg/mL (normal <100) and a gastric pH of 1.2. His stool Sudan stain is positive for fat. Octreotide scan localizes a mass to the pancreatic head. What mechanism explains his steatorrhea despite normal pancreatic and hepatic function?
APancreatic mass obstructs the main pancreatic duct, causing exocrine insufficiency
BExcess gastric acid inactivates bile salts and pancreatic lipase before they can function at the lipid-water interface
CElevated gastrin stimulates excessive gallbladder contraction, depleting the bile pool
DPancreatic mass causes secondary diabetes mellitus, which impairs enterocyte lipid transport
EThe tumor produces neurotensin, which inhibits lipase synthesis
B — Excess acid inactivates bile salts and pancreatic lipase (Zollinger-Ellison syndrome).Zollinger-Ellison syndrome (ZES) is caused by a gastrin-secreting neuroendocrine tumor (gastrinoma). Key pathophysiology: gastrinoma → massive gastric acid secretion → duodenal pH drops to <3 (normal optimum ~6–7) → both bile salts and pancreatic lipase are inactivated (protonated) → fat cannot be digested or emulsified → steatorrhea. This is a functional, not structural, insufficiency — pancreatic enzyme output is normal but nonfunctional. Classic vignette: refractory PUD + high gastrin + steatorrhea + pancreatic mass. Treatment: high-dose PPIs + surgical tumor resection if localized.
Question 12 of 5 — LO 3 · Terminal Ileum Resection Consequences
A 28-year-old man with Crohn's disease undergoes resection of 130 cm of terminal ileum. Postoperatively, he develops persistent watery diarrhea (3–4 loose stools daily) despite a low-fat diet. Stool Sudan stain is positive for fat. Labs show normal pancreatic function, normal liver function, and normal glucose. Identify TWO major consequences of terminal ileum resection related to bile and fat metabolism.
ALoss of intrinsic factor synthesis → B₁₂ deficiency and villous atrophy
BLoss of bile acid reabsorption (ASBT) → bile acid diarrhea + depleted pool → ↓ micelle formation → steatorrhea
CLoss of cholecystokinin production → gallbladder atony and hepatic stasis
DLoss of glucose transporters → secondary diabetes and osmotic diarrhea
ELoss of HCO₃⁻ secretion → duodenal pH drops to 3, inactivating pancreatic enzymes
B — Loss of bile acid reabsorption → diarrhea + steatorrhea; note: also B₁₂ deficiency (terminal ileum = IF-B₁₂ site). The terminal ileum has two critical absorption functions: (1) bile acid reabsorption via ASBT (95% of bile acids recirculate here), and (2) vitamin B₁₂ absorption via intrinsic factor binding. Post-resection: bile acids enter the colon → osmotic/secretory diarrhea (bile acid diarrhea). The depleted bile pool cannot form sufficient micelles → steatorrhea + fat-soluble vitamin (A, D, E, K) deficiency. Additionally, B₁₂ deficiency develops over months/years → megaloblastic anemia. Treatment includes cholestyramine for bile acid diarrhea and B₁₂ supplementation.
Question 13 of 5 — LO 4 · Abetalipoproteinemia
A 6-year-old boy presents with failure to thrive, severe steatorrhea, progressive ataxia, and visual disturbance (night blindness and peripheral vision loss). Physical exam reveals a peripheral blood smear with acanthocytes (spiky RBCs), and small bowel biopsy shows enterocytes packed with lipid droplets. What is the molecular defect, and why do enterocytes accumulate lipid despite normal absorption?
ADeficiency of pancreatic colipase; lipids are not fragmented into absorbable forms
BAbsent MTP (microsomal triglyceride transfer protein); enterocytes absorb FA/MG but CANNOT package them into chylomicrons
CASBT mutation; bile acid reabsorption fails → impaired micelle formation
DCholesterol 7α-hydroxylase deficiency; hepatic bile synthesis blocked at the first step
ELoss of brush border lipoprotein lipase; triglycerides cannot be hydrolyzed in the intestinal lumen
B — Absent MTP; enterocytes cannot export absorbed lipids as chylomicrons.Abetalipoproteinemia is an autosomal recessive disorder with absent microsomal triglyceride transfer protein (MTP). MTP catalyzes the packaging of absorbed fatty acids and monoglycerides into chylomicrons. Without MTP: enterocytes absorb FA/MG normally (via micelles) but cannot assemble them into chylomicrons for export → fat accumulates inside cells (biopsy finding) → lipids are expelled in stool (steatorrhea). Classic complications: acanthocytes (abnormal RBC membranes from lipid imbalance), vitamin E deficiency (causes ataxia and spinocerebellar degeneration), fat-soluble vitamin deficiency (A, D, K deficiency), and retinitis pigmentosa. Unlike CF or bile acid deficiency, the intestinal absorption step is intact — the problem is export.
Question 14 of 5 — LO 4 · Cystic Fibrosis & Pancreatic Insufficiency
A 4-year-old child with cystic fibrosis is evaluated for failure to thrive and recurrent greasy stools. His sweat chloride is 95 mEq/L (diagnostic), and abdominal imaging shows a small fatty pancreas with ductal dilatation. Labs show low serum albumin (2.8 g/dL) and normal liver synthetic function. What is the underlying pathophysiology of fat malabsorption in CF, and how does treatment differ from abetalipoproteinemia?
B — Pancreatic exocrine insufficiency; treatment = PERT (pancreatic enzyme replacement).Cystic fibrosis (CF) is a chloride channel disorder (CFTR gene) that causes thick, inspissated secretions obstructing ducts throughout the body. In the pancreas: thick mucus plugs obstruct pancreatic ducts → pancreatic acinar atrophy and fibrosis → loss of exocrine pancreatic enzymes (lipase, colipase, trypsin, amylase) → fat and protein cannot be digested → steatorrhea and protein malabsorption. Bile synthesis and secretion are NORMAL; the problem is absent digestive enzymes. Unlike abetalipoproteinemia (structural export defect) or bile acid malabsorption (reduced micelle formation), CF is enzyme deficiency. Treatment: pancreatic enzyme replacement therapy (PERT) — exogenous lipase, protease, and amylase with meals. Also fat-soluble vitamin supplements (A, D, E, K).
Question 15 of 5 — LO 2 · Cholestyramine & Bile Acid Metabolism
A 35-year-old woman with a history of terminal ileum resection for Crohn's disease develops intractable watery diarrhea (6–8 loose stools daily) despite dietary modifications. She is started on cholestyramine 8 g daily in divided doses. Explain the mechanism by which cholestyramine alleviates bile acid diarrhea AND lowers LDL cholesterol, and identify a potential adverse effect of chronic use.
ACholestyramine inhibits cholesterol 7α-hydroxylase; decreases bile acid synthesis and LDL precursors
BCholestyramine binds bile acids in the gut → ↓ enterohepatic reabsorption → ↑ hepatic bile acid synthesis (using cholesterol) → ↓ LDL; stops diarrhea by removing diarrheogenic bile acids from colon
CCholestyramine activates FXR (farnesoid X receptor); increases tight junction integrity and reduces colonic secretions
DCholestyramine restores normal ASBT function by enhancing gene expression
B — Cholestyramine sequesters bile → ↓ reabsorption → ↑ hepatic bile synthesis (using cholesterol) → ↓ LDL; also stops bile acid diarrhea.Cholestyramine is an anionic exchange resin that binds bile acids in the intestinal lumen, preventing their reabsorption. This interrupts enterohepatic circulation. Consequence: the liver must synthesize more bile acids to replace those lost → hepatic cholesterol consumption increases → ↓ serum LDL cholesterol. Additionally, by removing bile acids from the colon, cholestyramine prevents their osmotic/secretory diarrheal effects (treats bile acid diarrhea). Adverse effects: malabsorption of fat-soluble vitamins (A, D, E, K) with chronic use, constipation, and potential drug interactions (take cholestyramine 1 hour before or 4 hours after other medications).
Performance Dashboard
—
Total Score
—
Block 1
—
Block 2
—
Block 3
Question-by-Question Breakdown
Answer questions in the Exam Blocks to see your breakdown here.